Ted Getz, MD

he/him/his

Clinical Fellow

DownloadHi-Res Photo

About

Titles

Clinical Fellow

Biography

Ted Getz is a hematology/oncology fellow at Yale University & Yale Comprehensive Cancer Center. He graduated from Case Western Reserve University School of Medicine in 2020 and completed a residency in internal medicine at Weill-Cornell/New York Presbyterian Hospital. His clinical and research interests focus on myeloid malignancies, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Dr. Getz is actively involved in outcomes research, clinical trial methodology, and the development of institutional and multi-institutional registries to advance the care of patients with hematologic cancers.

Last Updated on August 30, 2025.

Appointments

Medical Oncology and Hematology
Clinical Fellow
Primary

Internal Medicine
Medical Oncology and Hematology

Education & Training

Resident: New York Presbyterian/Weill Cornell Medical Center (2023)

MD: Case Western Reserve University School of Medicine (2020)

BS: The University of Chicago, Biological Chemistry (2015)

Board Certifications

Internal Medicine
Certification Organization
ABIM
Original Certification Date
2023

Research

Overview

Medical Research Interests

Leukemia; Leukemia, Myeloid; Meta-Analysis; Multicenter Study

ORCID
0000-0001-9886-5624

Research at a Glance

Yale Co-Authors

Frequent collaborators of Ted Getz's published research.

Rory Shallis, MD
View Full Profile
View Common Publication
Stuart Seropian, MD
View Full Profile
View Common Publication

Publications

2025

Avapritinib monotherapy induces rapid and deep remission of heavily treated, KIT D816H-mutated t(8;21) acute myeloid leukemia, a case report and literature review
Getz T, Bakirhan K, Seropian S, Shallis R. Avapritinib monotherapy induces rapid and deep remission of heavily treated, KIT D816H-mutated t(8;21) acute myeloid leukemia, a case report and literature review. Annals Of Hematology 2025, 104: 3889-3892. PMID: 40576687, PMCID: PMC12334448, DOI: 10.1007/s00277-025-06388-w.
Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
MeSH Keywords and Concepts

2023

Antibody-drug conjugates for urothelial carcinoma.
Thomas J, Sun M, Getz T, Ho B, Nauseef JT, Tagawa ST. Antibody-drug conjugates for urothelial carcinoma. Urol Oncol 2023, 41: 420-428. PMID: 37419845, DOI: 10.1016/j.urolonc.2023.06.006.
Peer-Reviewed Original Research

2019

Rapid-Onset Vancomycin-Induced Thrombocytopenia With Reexposure.
Getz TM, Packer CD. Rapid-Onset Vancomycin-Induced Thrombocytopenia With Reexposure. Ann Pharmacother 2019, 53: 1259-1261. PMID: 31353923, DOI: 10.1177/1060028019867433.
Peer-Reviewed Case Reports and Technical Notes
Microbiomes of Inflammatory Thoracic Aortic Aneurysms Due to Giant Cell Arteritis and Clinically Isolated Aortitis Differ From Those of Non-Inflammatory Aneurysms.
Getz TM, Hoffman GS, Padmanabhan R, Villa-Forte A, Roselli EE, Blackstone E, Johnston D, Pettersson G, Soltesz E, Svensson LG, Calabrese LH, Clifford AH, Eng C. Microbiomes of Inflammatory Thoracic Aortic Aneurysms Due to Giant Cell Arteritis and Clinically Isolated Aortitis Differ From Those of Non-Inflammatory Aneurysms. Pathog Immun 2019, 4: 105-123. PMID: 30993253, DOI: 10.20411/pai.v4i1.269.
Peer-Reviewed Original Research
The Microbiome of Temporal Arteries.
Hoffman GS, Getz TM, Padmanabhan R, Villa-Forte A, Clifford AH, Funchain P, Sankunny M, Perry JD, Blandford A, Kosmorsky G, Lystad L, Calabrese LH, Eng C. The Microbiome of Temporal Arteries. Pathog Immun 2019, 4: 21-38. PMID: 30993251, DOI: 10.20411/pai.v4i1.270.
Peer-Reviewed Original Research

2018

The microbiome in PTEN hamartoma tumor syndrome.
Byrd V, Getz T, Padmanabhan R, Arora H, Eng C. The microbiome in PTEN hamartoma tumor syndrome. Endocr Relat Cancer 2018, 25: 233-243. PMID: 29233840, DOI: 10.1530/ERC-17-0442.
Peer-Reviewed Original Research

2016

Quantum dot-mediated delivery of siRNA to inhibit sphingomyelinase activities in brain-derived cells.
Getz T, Qin J, Medintz IL, Delehanty JB, Susumu K, Dawson PE, Dawson G. Quantum dot-mediated delivery of siRNA to inhibit sphingomyelinase activities in brain-derived cells. J Neurochem 2016, 139: 872-885. PMID: 27622309, DOI: 10.1111/jnc.13841.
Peer-Reviewed Original Research

Academic Achievements & Community Involvement

Activities

activity
Therapeutic Advances in Hematology
02/01/2025 - PresentJournal ServiceReviewer
activity
American Society of Hematology
10/01/2022 - PresentProfessional OrganizationsMember
activity
American Society of Clinical Oncology
07/01/2023 - PresentProfessional OrganizationsMember
activity
European Hematology Association
2024 - PresentProfessional OrganizationsMember

News

Get In Touch

Contacts

theodore.getz@yale.edu

Mailing Address

Yale Cancer Center

333 Cedar Street, PO Box 208028

New Haven, Connecticut 06520

United States

Titles

Biography

Appointments

Medical Oncology and Hematology

Other Departments & Organizations

Education & Training

Board Certifications

Internal Medicine

Overview

Medical Research Interests

ORCID

Research at a Glance

Yale Co-Authors

Rory Shallis, MD

Stuart Seropian, MD

Publications

2025

Avapritinib monotherapy induces rapid and deep remission of heavily treated, KIT D816H-mutated t(8;21) acute myeloid leukemia, a case report and literature review

2023

Antibody-drug conjugates for urothelial carcinoma.

2019

Rapid-Onset Vancomycin-Induced Thrombocytopenia With Reexposure.

Microbiomes of Inflammatory Thoracic Aortic Aneurysms Due to Giant Cell Arteritis and Clinically Isolated Aortitis Differ From Those of Non-Inflammatory Aneurysms.

The Microbiome of Temporal Arteries.

2018

The microbiome in PTEN hamartoma tumor syndrome.

2016

Quantum dot-mediated delivery of siRNA to inhibit sphingomyelinase activities in brain-derived cells.

Activities

Therapeutic Advances in Hematology

American Society of Hematology

American Society of Clinical Oncology

European Hematology Association

News

Yale research advances presented at American Society of Hematology annual meeting

Accolades, Awards & Honors

Yale research advances presented at American Society of Hematology annual meeting

Welcome New Postdocs, Postgrads, Fellows, Faculty & Staff! (August 2023)

Contacts